BioSET Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Employees
-
9
- Latest Deal Type
-
M&A
BioSET General Information
Description
Developer of synthetic bioactive peptides. The company develops synthetic peptides used for bone growth and tissue regeneration in the treatment of musculoskeletal, vascular and chronic wound diseases.
Contact Information
Website
www.biosetinc.comCorporate Office
- 9430 Key West Avenue
- Suite 220
- Rockville, MD 20850
- United States
Corporate Office
- 9430 Key West Avenue
- Suite 220
- Rockville, MD 20850
- United States
BioSET Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 16-Feb-2015 | Completed | Clinical Trials - Phase 3 | |||
| 4. Later Stage VC (Series D) | 10-May-2011 | Completed | Clinical Trials - Phase 3 | |||
| 3. Later Stage VC (Series C) | 11-Jun-2007 | Completed | Clinical Trials - Phase 3 | |||
| 2. Early Stage VC (Series B) | 30-Sep-2004 | $5.74M | $8.66M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 25-Feb-2002 | $2.92M | $2.92M | Completed | Startup |
BioSET Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C | ||||||||
| Series B | 9,900,000 | $0.001000 | $0.05 | $0.58 | $0.58 | 1x | $0.43 | 17.29% |
| Series A | 3,893,607 | $0.001000 | $0.06 | $0.75 | $0.75 | 1x | $0.48 | 7.93% |
BioSET Patents
BioSET Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2046350-A2 | Composition and method for delivery of bmp-2 amplifier/co-activator for enhancement of osteogenesis | Inactive | 22-Jun-2006 | ||
| EP-2046350-A4 | Composition and method for delivery of bmp-2 amplifier/co-activator for enhancement of osteogenesis | Inactive | 22-Jun-2006 | ||
| WO-2007150053-A2 | Composition and method for delivery of bmp-2 amplifier/co-activator for enhancement of osteogenesis | Inactive | 22-Jun-2006 | ||
| WO-2007150053-A3 | Composition and method for delivery of bmp-2 amplifier/co-activator for enhancement of osteogenesis | Inactive | 22-Jun-2006 | ||
| WO-2007150053-B1 | Composition and method for delivery of bmp-2 amplifier/co-activator for enhancement of osteogenesis | Inactive | 22-Jun-2006 | C07K14/4705 |
BioSET Signals
BioSET Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alloy Ventures | Venture Capital | Minority | ||
| EDF Ventures | Venture Capital | Minority | ||
| Heron Capital | Venture Capital | Minority | ||
| InnerDyne | Corporation | Minority | ||
| MB Venture Partners | Venture Capital | Minority |
BioSET FAQs
-
When was BioSET founded?
BioSET was founded in 2001.
-
Where is BioSET headquartered?
BioSET is headquartered in Rockville, MD.
-
What is the size of BioSET?
BioSET has 9 total employees.
-
What industry is BioSET in?
BioSET’s primary industry is Biotechnology.
-
Is BioSET a private or public company?
BioSET is a Private company.
-
What is BioSET’s current revenue?
The current revenue for BioSET is .
-
How much funding has BioSET raised over time?
BioSET has raised $26.3M.
-
Who are BioSET’s investors?
Alloy Ventures, EDF Ventures, Heron Capital, InnerDyne, and MB Venture Partners are 5 of 10 investors who have invested in BioSET.
-
When was BioSET acquired?
BioSET was acquired on 16-Feb-2015.
-
Who acquired BioSET?
BioSET was acquired by Ferring.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process